These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11712724)

  • 1. The use of transdermal fentanyl in pediatric oncology palliative care.
    Noyes M; Irving H
    Am J Hosp Palliat Care; 2001; 18(6):411-6. PubMed ID: 11712724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.
    Muijsers RB; Wagstaff AJ
    Drugs; 2001; 61(15):2289-307. PubMed ID: 11772140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal fentanyl for pain relief in a paediatric palliative care population.
    Hunt A; Goldman A; Devine T; Phillips M;
    Palliat Med; 2001 Sep; 15(5):405-12. PubMed ID: 11591092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of transdermal fentanyl patches in the effective management of cancer pain.
    Gibbs M
    Int J Palliat Nurs; 2009 Jul; 15(7):354-9. PubMed ID: 19648851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain management of cancer patients with transdermal fentanyl: a study of 1828 step I, II, & III transfers.
    Mystakidou K; Parpa E; Tsilika E; Katsouda E; Kouloulias V; Kouvaris J; Georgaki S; Vlahos L
    J Pain; 2004 Mar; 5(2):119-32. PubMed ID: 15042520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.
    Payne R; Mathias SD; Pasta DJ; Wanke LA; Williams R; Mahmoud R
    J Clin Oncol; 1998 Apr; 16(4):1588-93. PubMed ID: 9552070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
    Tawfik MO; Bryuzgin V; Kourteva G;
    Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK.
    Guest JF; Ruiz FJ; Russ J; Gupta RD; Mihai A; Greener M
    Curr Med Res Opin; 2005 Feb; 21(2):271-80. PubMed ID: 15801998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fentanyl transdermal system. Pain management at home.
    Woodroffe MA; Hays H
    Can Fam Physician; 1997 Feb; 43():268-72. PubMed ID: 9040914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.
    Payne R
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):47-53. PubMed ID: 9671331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.
    Kornick CA; Santiago-Palma J; Moryl N; Payne R; Obbens EA
    Drug Saf; 2003; 26(13):951-73. PubMed ID: 14583070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal fentanyl in the management of children with chronic severe pain: results from an international study.
    Finkel JC; Finley A; Greco C; Weisman SJ; Zeltzer L
    Cancer; 2005 Dec; 104(12):2847-57. PubMed ID: 16284992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-cycle fentanyl patch system significantly improves pain control in gynecologic cancer.
    Kanamori C; Kanamori T; Hayashi M; Yorioka H; Kanzaki H
    J Obstet Gynaecol Res; 2006 Dec; 32(6):605-9. PubMed ID: 17100824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal fentanyl for severe cancer-related pain.
    Yeo W; Lam KK; Chan AT; Leung TW; Nip SY; Johnson PJ
    Palliat Med; 1997 May; 11(3):233-9. PubMed ID: 9205657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
    Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
    Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
    Mitra F; Chowdhury S; Shelley M; Williams G
    Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.